Z

Zomedica Corp
AMEX:ZOM

Watchlist Manager
Zomedica Corp
AMEX:ZOM
Watchlist
Price: 0.13 USD -0.76% Market Closed
Market Cap: 127.4m USD
Have any thoughts about
Zomedica Corp?
Write Note

Zomedica Corp
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zomedica Corp
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zomedica Corp
AMEX:ZOM
Interest Income Expense
$4.1m
CAGR 3-Years
153%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Interest Income Expense
-$364m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
-15%
Boston Scientific Corp
NYSE:BSX
Interest Income Expense
-$564m
CAGR 3-Years
N/A
CAGR 5-Years
2%
CAGR 10-Years
-11%
Stryker Corp
NYSE:SYK
Interest Income Expense
$127m
CAGR 3-Years
23%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Interest Income Expense
-$247m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
-12%
Intuitive Surgical Inc
NASDAQ:ISRG
Interest Income Expense
$315.7m
CAGR 3-Years
54%
CAGR 5-Years
21%
CAGR 10-Years
39%
No Stocks Found

Zomedica Corp
Glance View

Market Cap
127.4m USD
Industry
Health Care

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company is headquartered in Ann Arbor, Michigan and currently employs 85 full-time employees. The company went IPO on 2013-10-28. The firm is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The firm's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF).

ZOM Intrinsic Value
0.13 USD
Overvaluation 3%
Intrinsic Value
Price
Z

See Also

What is Zomedica Corp's Interest Income Expense?
Interest Income Expense
4.1m USD

Based on the financial report for Sep 30, 2024, Zomedica Corp's Interest Income Expense amounts to 4.1m USD.

What is Zomedica Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
153%

Over the last year, the Interest Income Expense growth was -23%. The average annual Interest Income Expense growth rates for Zomedica Corp have been 153% over the past three years .

Back to Top